CTXR vs EVRG · rev $7.1M vs P/E 22, rev $5.96B
Citius Pharmaceuticals Inc (CTXR) versus Evergy, Inc. (EVRG) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported EVRG revenue for 2025-12-31 was $5.96B. Net income was $855.6M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
CTXR currently screens at market cap $13.4M. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Not investment advice. Open the CTXR and EVRG stock pages for the full models.
Not investment advice.